Informations: Ceci n’est pas la version la plus récente du modèle de données. Vous trouverez un aperçu de la version à gauche, sous Versions. Vous trouverez la version la plus actuelle ici.
Informations:
Erreur:
ID
23706
Description
Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00568841
Lien
https://clinicaltrials.gov/show/NCT00568841
Mots-clés
Versions (2)
- 11/07/2017 11/07/2017 -
- 11/07/2017 11/07/2017 -
Téléchargé le
11 juillet 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Carcinoma, Non-Small-Cell Lung NCT00568841
Eligibility Carcinoma, Non-Small-Cell Lung NCT00568841
- StudyEvent: Eligibility
Similar models
Eligibility Carcinoma, Non-Small-Cell Lung NCT00568841
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
≥ 18 years of age
boolean
C0001779 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma untreated TNM clinical staging
Item
untreated non-small-cell lung cancer stage iiib/iv
boolean
C0007131 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C0332155 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
Life Expectancy
Item
life expectancy > 3 months
boolean
C0023671 (UMLS CUI [1])
ECOG performance status
Item
performance status ecog 0-2
boolean
C1520224 (UMLS CUI [1])
Immunotherapy Systemic | Chemotherapy | Antineoplastic Agents
Item
concurrent systemic immune therapy, chemotherapy or therapy with any anticancer drug not indicated in the study protocol
boolean
C0021083 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2])
C0003392 (UMLS CUI [3])
C0205373 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2])
C0003392 (UMLS CUI [3])
Investigational New Drugs
Item
any investigational agent(s) within 4 weeks prior to study entry
boolean
C0013230 (UMLS CUI [1])
Targeted Therapy Epidermal Growth Factor Receptor | Antibodies | Small Molecule
Item
previous administration of any egfr-targeted therapy (antibodies, small molecules and others)
boolean
C2985566 (UMLS CUI [1,1])
C0034802 (UMLS CUI [1,2])
C3495458 (UMLS CUI [2])
C1328819 (UMLS CUI [3])
C0034802 (UMLS CUI [1,2])
C3495458 (UMLS CUI [2])
C1328819 (UMLS CUI [3])
Medical condition Excludes Clinical Trial Completion | Medical condition Preventing Comprehension Patient Information | Mental disorder Excludes Clinical Trial Completion | Mental disorder Preventing Comprehension Patient Information
Item
any medical, mental or psychological condition which in the opinion of the investigator would not permit the patient to complete the study or understand the patient information
boolean
C3843040 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,4])
C3843040 (UMLS CUI [2,1])
C1292733 (UMLS CUI [2,2])
C0162340 (UMLS CUI [2,3])
C1955348 (UMLS CUI [2,4])
C0004936 (UMLS CUI [3,1])
C0332196 (UMLS CUI [3,2])
C0008976 (UMLS CUI [3,3])
C0205197 (UMLS CUI [3,4])
C0004936 (UMLS CUI [4,1])
C1292733 (UMLS CUI [4,2])
C0162340 (UMLS CUI [4,3])
C1955348 (UMLS CUI [4,4])
C0332196 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,4])
C3843040 (UMLS CUI [2,1])
C1292733 (UMLS CUI [2,2])
C0162340 (UMLS CUI [2,3])
C1955348 (UMLS CUI [2,4])
C0004936 (UMLS CUI [3,1])
C0332196 (UMLS CUI [3,2])
C0008976 (UMLS CUI [3,3])
C0205197 (UMLS CUI [3,4])
C0004936 (UMLS CUI [4,1])
C1292733 (UMLS CUI [4,2])
C0162340 (UMLS CUI [4,3])
C1955348 (UMLS CUI [4,4])